Transgender Women's Experiences Using a Home HIV-Testing Kit for Partner-Testing.
AIDS Serodiagnosis
/ methods
Adult
Female
HIV Infections
/ diagnosis
Humans
Interviews as Topic
Male
Mass Screening
/ methods
New York City
Puerto Rico
Qualitative Research
Randomized Controlled Trials as Topic
Reagent Kits, Diagnostic
Self Care
/ methods
Serologic Tests
Sexual Behavior
Sexual Partners
Surveys and Questionnaires
Transgender Persons
/ psychology
Young Adult
HIV
HIV self-test
HIV testing
HIV/AIDS
Male partners
OraQuick
Partner HIV testing
Secondary distribution
Trans women
Transgender women
Transwomen
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
pubmed:
21
3
2020
medline:
21
8
2020
entrez:
21
3
2020
Statut:
ppublish
Résumé
HIV partner-testing (PT) may represent a unique and empowering HIV prevention strategy for groups that face structural and institutional barriers to HIV testing and care, including transgender women. We report on in-depth interviews (IDIs) with N = 10 transgender women who used HIV self-test kits for three months to screen potential sexual partners in a randomized controlled trial (iSUM; "I'll Show You Mine") that took place in New York City and San Juan, Puerto Rico. Participants were assigned to intervention (supplied with 10 self-test kits immediately) or control groups (received 6 test kits after 3 months). We conducted IDIs with the first N = 10 transgender women to enroll in the intervention group after three months in the study (after participants used kits with partners) to understand their experiences. Themes discussed in IDIs included: partners' reaction to HIV testing, participants' reactions to partners' test results or refusal to test, partners' own reaction to their test results, and decision-making around test use. Data were independently analyzed by two coders. Overwhelmingly, participants' experiences with PT was positive. Participants reported kits were convenient and acceptable to most partners. Transgender women felt that PT could pose additional risk for them; one woman experienced violence related to kit use. Furthermore, the availability of kits appeared to encourage participants and their partners to think about their HIV status and, in some cases, modify sexual behavior. Work suggests that HIV PT could be a viable risk-reduction strategy for transgender women.
Identifiants
pubmed: 32193729
doi: 10.1007/s10461-020-02829-x
pii: 10.1007/s10461-020-02829-x
pmc: PMC7725406
mid: NIHMS1581819
doi:
Substances chimiques
Reagent Kits, Diagnostic
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2732-2741Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR001870
Pays : United States
Organisme : NLM NIH HHS
ID : T15 LM007079
Pays : United States
Organisme : AHRQ HHS
ID : K12 HS026383
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH043520
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069415
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD076636
Pays : United States
Organisme : NIMHD NIH HHS
ID : P60 MD006902
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI113127
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM013045
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH43520
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM012355
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH115785
Pays : United States
Organisme : National Institute of Child Health and Human Development
ID : R01 AI113127
Références
AIDS Behav. 2012 Jan;16(1):1-4
pubmed: 21476006
AIDS Behav. 2009 Aug;13(4):731-7
pubmed: 19415483
AIDS Behav. 2018 Jan;22(1):347-357
pubmed: 29124420
PLoS Med. 2011 Nov;8(11):e1001124
pubmed: 22131907
AIDS Behav. 2012 Oct;16(7):1753-60
pubmed: 22893194
AIDS Behav. 2020 Feb;24(2):506-515
pubmed: 31865516
PLoS One. 2018 Jun 20;13(6):e0198606
pubmed: 29924873
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
BMC Public Health. 2013 Aug 08;13:735
pubmed: 23924387
Mhealth. 2019 Jun 18;5:17
pubmed: 31380409
Health Care Women Int. 2014;35(7-9):703-27
pubmed: 24564483
AIDS Behav. 2020 Jun;24(6):1929-1941
pubmed: 31853772
Int J STD AIDS. 2017 Nov;28(13):1341-1347
pubmed: 28449628
AIDS Behav. 2018 Nov;22(11):3627-3636
pubmed: 29589137
PLoS One. 2017 Mar 27;12(3):e0174629
pubmed: 28346527
Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):168-71
pubmed: 26910276
PLoS Med. 2016 Nov 8;13(11):e1002166
pubmed: 27824882
J Sex Res. 2012;49(4):379-87
pubmed: 22293029
Lancet HIV. 2016 Jun;3(6):e266-74
pubmed: 27240789
AIDS Behav. 2016 Apr;20(4):928-38
pubmed: 26511864
Lancet HIV. 2015 Dec;2(12):e512-9
pubmed: 26614965
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25251
pubmed: 30907508